US Firms Invest $50 Million in Israeli Marijuana Research

A cannabis leaf. Photo: The United States Fish and Wildlife Service via Wikimedia Commons.

A cannabis leaf. Photo: The United States Fish and Wildlife Service via Wikimedia Commons.

JNS.org – American firms have invested about $50 million in licensing Israeli medical marijuana patents, cannabis agro-tech start-ups, and companies developing delivery devices such as inhalers, scientists say.

“I expect it to grow to $100 million in the coming year,” Saul Kaye, CEO of Israel-based iCAN, said at the private cannabis research hub’s CannaTech conference in Tel Aviv in March.

Although 23 US states now allow the use of medical marijuana, with four states and Washington, DC, also allowing its recreational use, scientists claim stringent American rules set by the Drug Enforcement Administration (DEA) are limiting cannabis research in the US.

“In the United States it’s easier to study heroin than marijuana,” said US psychiatrist Suzanne Sisley,

... read more at: https://www.algemeiner.com/2016/03/31/us-firms-invest-50-million-in-israeli-marijuana-research/

by

Leave a Reply

Your email address will not be published. Required fields are marked *